Cargando…
In Silico Evaluation of CRISPR-Based Assays for Effective Detection of SARS-CoV-2
Coronavirus disease (COVID-19) caused by the SARS-CoV-2 has been an outbreak since late 2019 up to now. This pandemic causes rapid development in molecular detection technologies to diagnose viral infection for epidemic prevention. In addition to antigen test kit (ATK) and polymerase chain reaction...
Autores principales: | Kaewsapsak, Pornchai, Chantaravisoot, Naphat, Nimsamer, Pattaraporn, Mayuramart, Oraphan, Mankhong, Suwanan, Payungporn, Sunchai |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9506389/ https://www.ncbi.nlm.nih.gov/pubmed/36145402 http://dx.doi.org/10.3390/pathogens11090968 |
Ejemplares similares
-
Comparative performance of CRISPR-Cas12a assays for SARS-CoV-2 detection tested with RNA extracted from clinical specimens
por: Nimsamer, Pattaraporn, et al.
Publicado: (2021) -
Machine Learning-Driven and Smartphone-Based Fluorescence
Detection for CRISPR Diagnostic of SARS-CoV-2
por: Samacoits, Aubin, et al.
Publicado: (2021) -
IRF7-deficient MDCK cell based on CRISPR/Cas9 technology for enhancing influenza virus replication and improving vaccine production
por: Mayuramart, Oraphan, et al.
Publicado: (2022) -
Genome characterization and mutation analysis of human influenza A virus in Thailand
por: Rattanaburi, Somruthai, et al.
Publicado: (2022) -
Single-Drop Blood
Detection of Common G6PD Mutations in Thailand Based
on Allele-Specific Recombinase Polymerase Amplification with CRISPR-Cas12a
por: Mungkalasut, Punchalee, et al.
Publicado: (2023)